- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x DEB: 6-DEOXYERYTHRONOLIDE B(Non-covalent)
DEB.2: 16 residues within 4Å:- Chain A: M.83, F.84, L.94, L.179, I.243, A.244, T.248, S.295, F.296, L.396, I.397
- Ligands: HEM.1, RAM.3, GOL.7, FMT.13, FMT.55
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:M.83, A:F.84, A:L.179, A:A.244, A:T.248, A:I.397
- Water bridges: A:F.296
- 2 x RAM: alpha-L-rhamnopyranose(Non-covalent)
RAM.3: 13 residues within 4Å:- Chain A: E.89, G.92, V.93, M.178, Q.193, N.236, V.239, S.240, I.243
- Ligands: DEB.2, GOL.7, FMT.13, FMT.55
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:Q.193, A:I.243
- Hydrogen bonds: A:V.93, A:N.236, A:S.240, A:S.240
- Water bridges: A:S.240, A:S.240, A:S.240
RAM.4: 6 residues within 4Å:- Chain A: Q.96, D.100, H.228, T.230, E.233
- Ligands: FMT.28
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.96, A:D.100
- Water bridges: A:P.90
- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 10 residues within 4Å:- Chain A: D.67, S.68, F.70, T.72, Q.96, D.97, P.98, A.353, H.354
- Ligands: FMT.44
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:S.68, A:T.72, A:T.72, A:H.354
- Water bridges: A:R.298, A:A.353
GOL.6: 6 residues within 4Å:- Chain A: R.266, S.269, L.337, D.338, F.339, H.340
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:L.337, A:D.338, A:F.339, A:H.340
GOL.7: 10 residues within 4Å:- Chain A: F.84, T.86, P.87, P.88, E.89, Q.193
- Ligands: DEB.2, RAM.3, FMT.13, FMT.55
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:T.86, A:E.89, A:E.89, A:Q.193, A:Q.193
- Water bridges: A:T.86
- 58 x FMT: FORMIC ACID(Non-functional Binders)
FMT.8: 5 residues within 4Å:- Chain A: R.35, R.57, D.327, E.329
- Ligands: FMT.25
Ligand excluded by PLIPFMT.9: 5 residues within 4Å:- Chain A: F.112, H.355, C.356, I.357
- Ligands: FMT.59
Ligand excluded by PLIPFMT.10: 3 residues within 4Å:- Chain A: A.73, T.76
- Ligands: FMT.11
Ligand excluded by PLIPFMT.11: 4 residues within 4Å:- Chain A: T.76, D.77, P.90
- Ligands: FMT.10
Ligand excluded by PLIPFMT.12: 3 residues within 4Å:- Chain A: D.273, A.275, L.276
Ligand excluded by PLIPFMT.13: 8 residues within 4Å:- Chain A: E.89, G.92, L.94, A.95
- Ligands: DEB.2, RAM.3, GOL.7, FMT.55
Ligand excluded by PLIPFMT.14: 2 residues within 4Å:- Chain A: M.197, D.201
Ligand excluded by PLIPFMT.15: 2 residues within 4Å:- Chain A: P.90
- Ligands: FMT.27
Ligand excluded by PLIPFMT.16: 3 residues within 4Å:- Chain A: A.114, E.118, Q.360
Ligand excluded by PLIPFMT.17: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.18: 7 residues within 4Å:- Chain A: S.20, P.22, D.26, L.27, D.28, Y.31, R.398
Ligand excluded by PLIPFMT.19: 1 residues within 4Å:- Chain A: R.375
Ligand excluded by PLIPFMT.20: 1 residues within 4Å:- Chain A: G.162
Ligand excluded by PLIPFMT.21: 2 residues within 4Å:- Chain A: P.164, Q.206
Ligand excluded by PLIPFMT.22: 2 residues within 4Å:- Chain A: D.129, D.133
Ligand excluded by PLIPFMT.23: 2 residues within 4Å:- Chain A: R.42, E.315
Ligand excluded by PLIPFMT.24: 3 residues within 4Å:- Chain A: P.141, I.404
- Ligands: FMT.61
Ligand excluded by PLIPFMT.25: 5 residues within 4Å:- Chain A: R.35, R.326, D.327, E.328
- Ligands: FMT.8
Ligand excluded by PLIPFMT.26: 4 residues within 4Å:- Chain A: V.145, V.150, R.172, E.401
Ligand excluded by PLIPFMT.27: 6 residues within 4Å:- Chain A: P.87, E.89, Q.190, Q.193
- Ligands: FMT.15, FMT.54
Ligand excluded by PLIPFMT.28: 5 residues within 4Å:- Chain A: D.97, P.98, P.99, D.100
- Ligands: RAM.4
Ligand excluded by PLIPFMT.29: 3 residues within 4Å:- Chain A: R.172, T.173, D.176
Ligand excluded by PLIPFMT.30: 2 residues within 4Å:- Chain A: P.18, F.19
Ligand excluded by PLIPFMT.31: 3 residues within 4Å:- Chain A: L.160, D.214, L.215
Ligand excluded by PLIPFMT.32: 3 residues within 4Å:- Chain A: R.123, S.126, S.130
Ligand excluded by PLIPFMT.33: 1 residues within 4Å:- Chain A: Y.47
Ligand excluded by PLIPFMT.34: 3 residues within 4Å:- Chain A: H.351, G.352
- Ligands: FMT.36
Ligand excluded by PLIPFMT.35: 5 residues within 4Å:- Chain A: R.62, G.66, D.67, H.351
- Ligands: FMT.47
Ligand excluded by PLIPFMT.36: 3 residues within 4Å:- Chain A: G.352, A.353
- Ligands: FMT.34
Ligand excluded by PLIPFMT.37: 1 residues within 4Å:- Ligands: FMT.59
Ligand excluded by PLIPFMT.38: 3 residues within 4Å:- Chain A: V.330, R.343, P.345
Ligand excluded by PLIPFMT.39: 4 residues within 4Å:- Chain A: R.123, L.127, E.159
- Ligands: FMT.53
Ligand excluded by PLIPFMT.40: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.41: 3 residues within 4Å:- Chain A: E.268, V.271, A.272
Ligand excluded by PLIPFMT.42: 2 residues within 4Å:- Chain A: S.20, L.21
Ligand excluded by PLIPFMT.43: 3 residues within 4Å:- Chain A: A.32, E.33, R.36
Ligand excluded by PLIPFMT.44: 3 residues within 4Å:- Chain A: S.68, P.98
- Ligands: GOL.5
Ligand excluded by PLIPFMT.45: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.46: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.47: 1 residues within 4Å:- Ligands: FMT.35
Ligand excluded by PLIPFMT.48: 4 residues within 4Å:- Chain A: G.48, E.49, P.78, R.82
Ligand excluded by PLIPFMT.49: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.50: 4 residues within 4Å:- Chain A: H.333, R.341, E.342
- Ligands: FMT.60
Ligand excluded by PLIPFMT.51: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.52: 1 residues within 4Å:- Ligands: FMT.62
Ligand excluded by PLIPFMT.53: 3 residues within 4Å:- Chain A: M.120, R.123
- Ligands: FMT.39
Ligand excluded by PLIPFMT.54: 5 residues within 4Å:- Chain A: E.89, Q.190, Q.193, Q.194
- Ligands: FMT.27
Ligand excluded by PLIPFMT.55: 8 residues within 4Å:- Chain A: P.88, E.89, A.95, F.296
- Ligands: DEB.2, RAM.3, GOL.7, FMT.13
Ligand excluded by PLIPFMT.56: 5 residues within 4Å:- Chain A: E.282, N.344, H.346, R.363
- Ligands: FMT.57
Ligand excluded by PLIPFMT.57: 4 residues within 4Å:- Chain A: F.349, H.355, R.363
- Ligands: FMT.56
Ligand excluded by PLIPFMT.58: 5 residues within 4Å:- Chain A: L.27, A.32, R.35, R.326, D.335
Ligand excluded by PLIPFMT.59: 6 residues within 4Å:- Chain A: R.105, G.109, I.357
- Ligands: FMT.9, FMT.37, FMT.63
Ligand excluded by PLIPFMT.60: 5 residues within 4Å:- Chain A: V.330, F.331, D.332, R.341
- Ligands: FMT.50
Ligand excluded by PLIPFMT.61: 3 residues within 4Å:- Chain A: H.138, E.146
- Ligands: FMT.24
Ligand excluded by PLIPFMT.62: 1 residues within 4Å:- Ligands: FMT.52
Ligand excluded by PLIPFMT.63: 3 residues within 4Å:- Chain A: G.109, T.113
- Ligands: FMT.59
Ligand excluded by PLIPFMT.64: 2 residues within 4Å:- Chain A: E.166, D.167
Ligand excluded by PLIPFMT.65: 5 residues within 4Å:- Chain A: P.22, H.23, A.24, W.391, Q.393
Ligand excluded by PLIP- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x DEB: 6-DEOXYERYTHRONOLIDE B(Non-covalent)
- 2 x RAM: alpha-L-rhamnopyranose(Non-covalent)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 58 x FMT: FORMIC ACID(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
C